Toxicity after radiochemotherapy for glioblastoma using temozolomide - a retrospective evaluation
<p>Abstract</p> <p>Purpose</p> <p>Retrospective evaluation of toxicity and results after radiochemotherapy for glioblastoma.</p> <p>Methods</p> <p>46 patients with histopathologically proven glioblastoma received simultaneous radiochemotherapy (R...
Main Authors: | Niewald Marcus, Berdel Christian, Fleckenstein Jochen, Licht Norbert, Ketter Ralf, Rübe Christian |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-10-01
|
Series: | Radiation Oncology |
Subjects: | |
Online Access: | http://www.ro-journal.com/content/6/1/141 |
Similar Items
-
Accelerated hyperfractionated radiochemotherapy with temozolomide is equivalent to normofractionated radiochemotherapy in a retrospective analysis of patients with glioblastoma
by: Victor Lewitzki, et al.
Published: (2019-12-01) -
Patterns of recurrence and outcomes of glioblastoma multiforme treated with chemoradiation and adjuvant temozolomide
by: Alexandre Ciuffi Faustino, et al.
Published: (2020-09-01) -
Phase I/II study testing the combination of AGuIX nanoparticles with radiochemotherapy and concomitant temozolomide in patients with newly diagnosed glioblastoma (NANO-GBM trial protocol)
by: Emilie Thivat, et al.
Published: (2023-04-01) -
Kalata B1 Enhances Temozolomide Toxicity to Glioblastoma Cells
by: Samantha L. Gerlach, et al.
Published: (2024-09-01) -
Feasibility and clinical usefulness of modelling glioblastoma migration in adjuvant radiotherapy
by: Sven Knobe, et al.
Published: (2022-05-01)